We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$156B
1-Year Est. Return
27.51%
This Fund
S&P 500
This Quarter
Est. Return
+5.54%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.97%
AUM
$49.6B
AUM Growth
+$5.62B
(+13%)
Cap. Flow
+$2.56B
Cap. Flow
% of AUM
5.15%
Top 10 Holdings %
Top 10 Hldgs %
6.81%
Holding
1,885
New
111
Increased
738
Reduced
863
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$178M |
| 2 |
Schwab Fundamental International Large Company Index ETF
FNDF
|
+$161M |
| 3 |
KLA
KLAC
|
+$151M |
| 4 |
Zions Bancorporation
ZION
|
+$148M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ingredion
INGR
|
+$85.6M |
| 2 |
Keysight
KEYS
|
+$83.3M |
| 3 |
ATI
ATI
|
+$81.4M |
| 4 |
Kennametal
KMT
|
+$66.6M |
| 5 |
Keurig Dr Pepper
KDP
|
+$65.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.46% |
| 2 | Industrials | 15.08% |
| 3 | Technology | 14.03% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Hyatt Hotels
H
$16.9B
| $3.54M | 0.01% |
46,436
-2,769
| -6% | -$209K |
|
952
Arrow Electronics
ARW
$11.6B
| $3.53M | 0.01% |
49,479
+6,754
| +16% | +$498K |
|
953
Vertex Pharmaceuticals
VRTX
$123B
| $3.5M | 0.01% |
19,094
+67
| +0.4% | +$11.7K |
|
|
VAR
954
DELISTED
Varian Medical Systems, Inc.
VAR
| $3.49M | 0.01% |
25,651
+111
| +0.4% | +$14.8K |
|
955
Waters Corp
WAT
$39.3B
| $3.49M | 0.01% |
16,210
+2,027
| +14% | +$443K |
|
956
Chipotle Mexican Grill
CMG
$43.7B
| $3.49M | 0.01% |
237,850
-13,800
| -5% | -$195K |
|
957
Copart
CPRT
$26.8B
| $3.48M | 0.01% |
186,284
+304
| +0.2% | +$5.22K |
|
958
Nordson
NDSN
$17.3B
| $3.48M | 0.01% |
24,598
+186
| +0.8% | +$25.6K |
|
959
Fortune Brands Innovations
FBIN
$6.24B
| $3.47M | 0.01% |
71,155
+164
| +0.2% | +$7.3K |
|
|
EIDX
960
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $3.44M | 0.01% |
110,730
-72,440
| -40% | -$1.96M |
|
961
Lear
LEA
$8.34B
| $3.42M | 0.01% |
24,583
+5,770
| +31% | +$809K |
|
|
DISH
962
DELISTED
DISH Network Corp.
DISH
| $3.42M | 0.01% |
88,975
+16,771
| +23% | +$595K |
|
963
Molson Coors Class B
TAP
$7.85B
| $3.42M | 0.01% |
61,004
+9,653
| +19% | +$563K |
|
964
TransUnion
TRU
$15.3B
| $3.41M | 0.01% |
46,442
-699,068
| -94% | -$47.8M |
|
965
Applied Materials
AMAT
$424B
| $3.4M | 0.01% |
75,657
+4,859
| +7% | +$205K |
|
|
FLIR
966
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $3.38M | 0.01% |
62,468
+107
| +0.2% | +$5.43K |
|
967
East-West Bancorp
EWBC
$18.3B
| $3.38M | 0.01% |
72,219
+10,504
| +17% | +$503K |
|
968
Sensata Technologies
ST
$6.93B
| $3.37M | 0.01% |
68,666
+355
| +0.5% | +$16.9K |
|
969
Washington Trust Bancorp
WASH
$753M
| $3.34M | 0.01% |
64,005
-3,915
| -6% | -$199K |
|
970
McKesson
MCK
$103B
| $3.31M | 0.01% |
24,662
+21,851
| +777% | +$2.72M |
|
971
Donaldson
DCI
$11.3B
| $3.31M | 0.01% |
65,124
+1,063
| +2% | +$54K |
|
972
ResMed
RMD
$32.4B
| $3.3M | 0.01% |
27,033
+153
| +0.6% | +$16.9K |
|
973
VeriSign
VRSN
$26.5B
| $3.29M | 0.01% |
15,718
+54
| +0.3% | +$10.6K |
|
974
Allison Transmission
ALSN
$9.8B
| $3.28M | 0.01% |
70,692
-210,757
| -75% | -$9.55M |
|
|
GRTS
975
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $3.26M | 0.01% |
293,030
+22,190
| +8% | +$254K |
|
Similar funds
Victory Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Victory Capital Management held 1,885 positions worth $49.6B, up 13% from $44B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
Victory Capital Management deployed $2.56B of net new capital in Q2 2019, opening 111 new positions and adding to 738 existing holdings. Its largest new stake was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 3,081,520 shares worth $181M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Ingredion, an estimated $85.6M trimmed.
- Victory Capital Management's largest Q2 2019 buy was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 3,081,520 shares worth $181M.
- Victory Capital Management added most to KLA in Q2 2019, an estimated $151M increase.
- Victory Capital Management's biggest Q2 2019 reduction was Ingredion, cutting an estimated $85.6M.
- Victory Capital Management fully exited Teladoc Health in Q2 2019, selling an estimated $50.5M.
- Victory Capital Management's ten largest holdings make up 6.8% of its $49.6B portfolio in Q2 2019.
- Victory Capital Management opened 111 new positions and closed 63 in Q2 2019.
- Victory Capital Management's portfolio value rose 13% quarter-over-quarter to $49.6B.
Based on Victory Capital Management's 13F filing for Q2 2019, filed 15 Aug 2019.